DetailsChartProfileRisk matrixNewsDocuments

Bellevue F.(L)-B.He.Strategy B CHF/  LU1477743113  /

Fonds
NAV3/28/2023 Chg.-0.9200 Type of yield Investment Focus Investment company
200.0600CHF -0.46% reinvestment Equity Waystone M.Co.(Lux) ▶
     
Chart for Bellevue F.(L)-B.He.Strategy B CHF
  Name   ISIN Performance Volatility Sharpe ratio
1. Polar Capital Healthcare Opport.I GBP IE00B3NLDF60 +5.64% 18.94% 0.14
2. J.Henderson Gl.Life Sciences F.H2 IE00B8GQ0T69 +5.72% 17.38% 0.16
3. Polar Capital Healthcare Opport.R GBP IE00B3NM2Q33 +5.14% 18.93% 0.11
4. Polar Capital Healthcare Opport.GBP IE00B28YJP58 +5.15% 18.95% 0.11
5. Candriam Equities L Oncology Impact I LU1864482515 +3.43% 17.46% 0.02
6. Candriam Equities L Oncology Impact R LU1864482945 +3.32% 17.46% 0.02
7. BGF World Healthscience I2 JPY LU2263536315 +2.97% 19.85% 0.00
8. AXA Framlington Health R Acc GB0003506424 +0.59% 17.50% -0.14
9. Polar Capital Healthcare Opport.I EUR IE00B3K83P04 +0.78% 18.82% -0.12
10. J.Henderson Gl.Life Sciences F.A2 IE00BRJG7840 +0.94% 17.64% -0.12
...
297. Bellevue F.(L)-B.He.Strategy B CHF LU1477743113 -14.87% 15.95% -1.12